525 related articles for article (PubMed ID: 12805240)
1. Vascular endothelial growth factor-B promotes in vivo angiogenesis.
Silvestre JS; Tamarat R; Ebrahimian TG; Le-Roux A; Clergue M; Emmanuel F; Duriez M; Schwartz B; Branellec D; Lévy BI
Circ Res; 2003 Jul; 93(2):114-23. PubMed ID: 12805240
[TBL] [Abstract][Full Text] [Related]
2. All in the family: VEGF-B joins the ranks of proangiogenic cytokines.
Yoon YS; Losordo DW
Circ Res; 2003 Jul; 93(2):87-90. PubMed ID: 12881472
[No Abstract] [Full Text] [Related]
3. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
[TBL] [Abstract][Full Text] [Related]
4. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
[TBL] [Abstract][Full Text] [Related]
5. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
[TBL] [Abstract][Full Text] [Related]
6. Very-low-dose combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide induces an early and sustained increase in neovascularization in rat ischemic legs.
Silvestre JS; Kamsu-Kom N; Clergue M; Duriez M; Lévy BI
J Pharmacol Exp Ther; 2002 Dec; 303(3):1038-43. PubMed ID: 12438525
[TBL] [Abstract][Full Text] [Related]
7. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model.
Namba T; Koike H; Murakami K; Aoki M; Makino H; Hashiya N; Ogihara T; Kaneda Y; Kohno M; Morishita R
Circulation; 2003 Nov; 108(18):2250-7. PubMed ID: 14568906
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylated endothelial nitric oxide synthase mediates vascular endothelial growth factor-induced penile erection.
Musicki B; Palese MA; Crone JK; Burnett AL
Biol Reprod; 2004 Feb; 70(2):282-9. PubMed ID: 14522830
[TBL] [Abstract][Full Text] [Related]
10. The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice.
Huusko J; Merentie M; Dijkstra MH; Ryhänen MM; Karvinen H; Rissanen TT; Vanwildemeersch M; Hedman M; Lipponen J; Heinonen SE; Eriksson U; Shibuya M; Ylä-Herttuala S
Cardiovasc Res; 2010 Apr; 86(1):122-30. PubMed ID: 19955220
[TBL] [Abstract][Full Text] [Related]
11. [Involvement of AKT/eNOS in brain derived neurotrophic factor-induced angiogenesis].
Wang YD; Hu Y; Sun CY; He WJ; Zhang XP
Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):529-33. PubMed ID: 17172126
[TBL] [Abstract][Full Text] [Related]
12. A novel vasculo-angiogenic effect of cilostazol mediated by cross-talk between multiple signalling pathways including the ERK/p38 MAPK signalling transduction cascade.
Chao TH; Tseng SY; Li YH; Liu PY; Cho CL; Shi GY; Wu HL; Chen JH
Clin Sci (Lond); 2012 Aug; 123(3):147-59. PubMed ID: 22339730
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
[TBL] [Abstract][Full Text] [Related]
14. Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways.
Wang Y; Wei X; Xiao X; Hui R; Card JW; Carey MA; Wang DW; Zeldin DC
J Pharmacol Exp Ther; 2005 Aug; 314(2):522-32. PubMed ID: 15840765
[TBL] [Abstract][Full Text] [Related]
15. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
[TBL] [Abstract][Full Text] [Related]
16. Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin.
Urbich C; Reissner A; Chavakis E; Dernbach E; Haendeler J; Fleming I; Zeiher AM; Kaszkin M; Dimmeler S
FASEB J; 2002 May; 16(7):706-8. PubMed ID: 11978735
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia.
Witzenbichler B; Asahara T; Murohara T; Silver M; Spyridopoulos I; Magner M; Principe N; Kearney M; Hu JS; Isner JM
Am J Pathol; 1998 Aug; 153(2):381-94. PubMed ID: 9708799
[TBL] [Abstract][Full Text] [Related]
18. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
[TBL] [Abstract][Full Text] [Related]
19. Heat shock cognate protein 70 is essential for Akt signaling in endothelial function.
Shiota M; Kusakabe H; Izumi Y; Hikita Y; Nakao T; Funae Y; Miura K; Iwao H
Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):491-7. PubMed ID: 20018937
[TBL] [Abstract][Full Text] [Related]
20. VEGF and inhibitors of TGFbeta type-I receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression.
Liu Z; Kobayashi K; van Dinther M; van Heiningen SH; Valdimarsdottir G; van Laar T; Scharpfenecker M; Löwik CW; Goumans MJ; Ten Dijke P; Pardali E
J Cell Sci; 2009 Sep; 122(Pt 18):3294-302. PubMed ID: 19706683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
